Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Flynn

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2016
Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast CancerKari B Wisinski, Amye J Tevaarwerk, Mark E Burkard, et al.
International Journal of Audiology|October 4, 2017
Hearing aid fitting and developmental outcomes of children fit according to either the NAL or DSL prescription: fit-to-target, audibility, speech and language abilitiesTeresa Y C Ching, Vicky W Zhang, Earl E Johnson, et al.
Molecular Cancer Research : MCR|October 21, 2021
The Epithelial-Stromal Microenvironment in Early Colonic NeoplasiaTakayasu Ideta, Boyang Li, Christopher Flynn, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 30, 2021
HER2 Expression in Endometrial Cancers Diagnosed as Clear Cell CarcinomaAlain Cagaanan, Bradly Stelter, Nhu Vu, et al.
Biochemical Pharmacology|September 5, 2006
Circumvention and reactivation of the p53 oncogene checkpoint in mouse colon tumorsWataru Aizu, Glenn S Belinsky, Christopher Flynn, et al.
Cancer Research|April 5, 2005
Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesisJillian N M Ilsley, Masako Nakanishi, Christopher Flynn, et al.
International Journal of Audiology|September 1, 2012
A randomized controlled comparison of NAL and DSL prescriptions for young children: hearing-aid characteristics and performance outcomes at three years of ageTeresa Y C Ching, Harvey Dillon, Sanna Hou, et al.
International Journal of Audiology|December 20, 2013
A randomized controlled trial of nonlinear frequency compression versus conventional processing in hearing aids: speech and language of children at three years of ageTeresa Y C Ching, Julia Day, Vicky Zhang, et al.
Cancer Research|September 18, 2004
Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancerPrashant R Nambiar, Masako Nakanishi, Rishi Gupta, et al.
Ear and Hearing|March 7, 2013
Outcomes of early- and late-identified children at 3 years of age: findings from a prospective population-based studyTeresa Y C Ching, Harvey Dillon, Vivienne Marnane, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2016
Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast CancerKari B Wisinski, Amye J Tevaarwerk, Mark E Burkard, et al.
International Journal of Audiology|October 4, 2017
Hearing aid fitting and developmental outcomes of children fit according to either the NAL or DSL prescription: fit-to-target, audibility, speech and language abilitiesTeresa Y C Ching, Vicky W Zhang, Earl E Johnson, et al.
Molecular Cancer Research : MCR|October 21, 2021
The Epithelial-Stromal Microenvironment in Early Colonic NeoplasiaTakayasu Ideta, Boyang Li, Christopher Flynn, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 30, 2021
HER2 Expression in Endometrial Cancers Diagnosed as Clear Cell CarcinomaAlain Cagaanan, Bradly Stelter, Nhu Vu, et al.
Biochemical Pharmacology|September 5, 2006
Circumvention and reactivation of the p53 oncogene checkpoint in mouse colon tumorsWataru Aizu, Glenn S Belinsky, Christopher Flynn, et al.
Cancer Research|April 5, 2005
Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesisJillian N M Ilsley, Masako Nakanishi, Christopher Flynn, et al.
International Journal of Audiology|September 1, 2012
A randomized controlled comparison of NAL and DSL prescriptions for young children: hearing-aid characteristics and performance outcomes at three years of ageTeresa Y C Ching, Harvey Dillon, Sanna Hou, et al.
International Journal of Audiology|December 20, 2013
A randomized controlled trial of nonlinear frequency compression versus conventional processing in hearing aids: speech and language of children at three years of ageTeresa Y C Ching, Julia Day, Vicky Zhang, et al.
Cancer Research|September 18, 2004
Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancerPrashant R Nambiar, Masako Nakanishi, Rishi Gupta, et al.
Ear and Hearing|March 7, 2013
Outcomes of early- and late-identified children at 3 years of age: findings from a prospective population-based studyTeresa Y C Ching, Harvey Dillon, Vivienne Marnane, et al.
Pageof 5